Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients
Merck Takes 3 Major Shots at COVID-19
Researchers define exactly what they saw in the first positive remdesivir study for Covid-19. But what's that worth to Gilead?
Novavax’s COVID-19 Vaccine Candidate Could Be the One, Says Top Analyst
Mammoth Biosciences teams with GSK to put Covid-19 CRISPR tests at home, airports, borders
Gilead Still Holds the Winning Hand, Says 5-Star Analyst
Novavax Seeks To Raise $250 Million From Share Sale; Top Analyst Bumps Up PT
Moderna Prices $1.3B Equity Offering at $76/Share
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
Europe Could Conditionally Approve Gilead’s Remdesivir In Next Few Days
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Applied DNA Sciences Tackles COVID-19 on Three Fronts; Analyst Says 'Buy'
FDA grants emergency approval to simpler ventilator design
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
Covid-19 roundup: Gilead selects 5 generic manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
FDA issues two guidances to accelerate Covid-19 treatments
Gilead Signs Remdesivir Licensing Agreements With Five Drugmakers
CEO Albert Bourla On Pfizer’s Involvement With Covid-19
Quidel’s Rapid Covid-19 Antigen Test Scores Emergency FDA Approval
Gilead’s Remdesivir Will Be Distributed By State Health Departments
FDA creates umbrella emergency pathway for COVID-19 serology tests
JPMorgan's Bullish Stance on Gilead Sciences (GILD) Stock Comes to an End
UPDATED: FDA cheers on Gilead's remdesivir with a snap emergency OK, giving biopharma a shot at redemption
SFU professor’s invention approved by FDA to help wean COVID-19 patients from ventilators